3SBio Inc. is a fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. The Company鈥檚 recombinant, or genetically engineered, protein-based products and product candidates are designed to address large markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO. In addition, it has two legacy products, Intefen and Inleusin, and an in-licensed product, Iron Sucrose Supplement. It is pursuing eight product candidates in late, mid and early-stage clinical and pre-clinical development, including a high dosage EPIAO, NuPIAO, a new indication for its TPIAO to treat idiopathic thrombocytopenic purpura (ITP), NuLeusin, a HPV vaccine for the prevention of cervical cancer, an anti-TNF monoclonal antibody product candidate, Feraheme (ferumoxytol) and Feraheme (ferumoxytol).